Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews

BACKGROUND: Sorafenib is the standard treatment for most cases of advanced hepatocellular carcinoma (HCC), based on Western and Eastern clinical guidelines. Thus, an increasing number of transarterial chemoembolization (TACE) plus sorafenib combination therapies have been used in clinical practice....

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jingxin, Wen, Yonghao, Deng, Manjun, Ye, Bin, Liu, Xinlian, Zhang, Lushun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561755/
https://www.ncbi.nlm.nih.gov/pubmed/37817915
http://dx.doi.org/10.2147/JHC.S429352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561755/
https://www.ncbi.nlm.nih.gov/pubmed/37817915
http://dx.doi.org/10.2147/JHC.S429352

Ejemplares similares